Abstract
Objective: The objective of this study was to derive a measure of quality-time to be used in treatment evaluations for gastroesophageal reflux disease (reflux disease). Specifically, we sought to refine the Extended Quality-adjusted Time without Symptoms and Toxicities (Q-TWiST) approach and propose a new measure, called Quality-Days Incrementally Gained (QDIG).
Design: One hundred and sixty-seven patients with reflux disease randomized to one of two treatments completed a health-related quality-of-life questionnaire at baseline and after four and eight weeks of treatment. The questionnaire contains generic and reflux disease-specific measures and corresponding importance items. The weighted assessment score, fundamental to calculating both the Extended Q-TWiST and the QDIG, was computed using several weighting schemes to determine the most robust and appropriate statistic.
Main Outcome Measures and Results: The Extended Q-TWiST was affected by the relative weighting of baseline and follow-up weighted assessment score. The QDIG directly discounts the baseline score and showed the greatest sensitivity to treatment differences. The variance in the Extended Q-TWiST and QDIG were both reduced by using importance weights carried forward from baseline rather than time-varying importance weights, and by using population-weights rather than individual person weights.
Conclusions: Careful consideration should be made when deciding to use the Extended Q-TWiST or QDIG approach. Our data suggest the QDIG approach is superior in studies of short duration with heterogeneous populations.
Get full access to this article
View all access options for this article.
